Concepedia

Publication | Closed Access

111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.

134

Citations

0

References

2000

Year

Raymond M. Reilly, Reza Kiarash, Ross Cameron, Nicole Porlier, Jasbir Sandhu, Rićhard P. Hill, Katherine A. Vallis, Aaron Hendler, Jean Gariépy
PubMed

Abstract

111In-DTPA-hEGF is a promising novel radiopharmaceutical for targeted Auger electron radiotherapy of advanced, hormone-resistant breast cancer.